Related Experiment Videos
Impaired levodopa response in Parkinson's disease during melanoma therapy
M Merello1, M Esteguy, F Perazzo
1Fleni (Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia), Buenos Aires, Argentina.
Clinical Neuropharmacology
|February 1, 1992
Abstract:
A patient with melanoma and sporadic positive melanuria developed Parkinson's disease. Treatment with levodopa failed to modify tumoral progress. However, during chemotherapy with dacarbazine, the patient experienced a significant impairment to levodopa response.